The role of rho and rho-dependent kinase in serotonin-induced contraction observed in bovine middle cerebral artery

Tohoku J Exp Med. 2003 Dec;201(4):239-49. doi: 10.1620/tjem.201.239.

Abstract

The current study was designed to characterize the role of Rho and Rho-dependent kinase (Rho-kinase) in isometric contractile responses induced by serotonin (5-HT) and a solution containing 40 mM K(+) (high K(+)) in ring preparations of the middle cerebral artery of bovine. Application of W-7, a Ca(2+)-calmodulin inhibitor, reversibly and equally attenuated the amplitudes of contractions produced by both 5-HT and high K(+). Similar effects were observed with ML-7, an inhibitor of myosin light chain kinase. Surprisingly, the protein kinase C inhibitors, calphostin C and Ro-31-8220, had no effect on the 5-HT-induced contraction. Incubation of preparations with Clostridium difficile toxin A and B or with Clostridium botulinum C3 exoenzyme for 48 hours attenuated the 5-HT-induced response but not the high K(+)-induced response. Application of the Rho-kinase inhibitor, Y-27632, resulted in marked inhibition of the 5-HT-induced response but had negligible effect on the high K(+)-induced response. These results suggest that the activation of Rho and Rho-kinase may be involved in the generation of the contraction produced by 5-HT in the bovine middle cerebral artery, while protein kinase C plays, if any, an insignificant role on the contraction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ADP Ribose Transferases / metabolism
  • Amides / pharmacology
  • Animals
  • Azepines / pharmacology
  • Bacterial Proteins*
  • Bacterial Toxins / pharmacology
  • Botulinum Toxins / metabolism
  • Brain
  • Calcium-Calmodulin-Dependent Protein Kinases / antagonists & inhibitors
  • Cattle
  • Cerebral Arteries / drug effects*
  • Cerebral Arteries / metabolism
  • Cytotoxins / pharmacology
  • Dose-Response Relationship, Drug
  • Enterotoxins / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Indoles / pharmacology
  • Intracellular Signaling Peptides and Proteins
  • Middle Cerebral Artery / drug effects*
  • Middle Cerebral Artery / metabolism
  • Myosin-Light-Chain Kinase / antagonists & inhibitors
  • Naphthalenes / antagonists & inhibitors
  • Naphthalenes / pharmacology
  • Potassium / metabolism
  • Protein Kinase C / antagonists & inhibitors
  • Protein Serine-Threonine Kinases / physiology*
  • Pyridines / pharmacology
  • Serotonin / pharmacology*
  • Sulfonamides / pharmacology
  • Time Factors
  • rho GTP-Binding Proteins / physiology*
  • rho-Associated Kinases

Substances

  • Amides
  • Azepines
  • Bacterial Proteins
  • Bacterial Toxins
  • Cytotoxins
  • Enterotoxins
  • Enzyme Inhibitors
  • Indoles
  • Intracellular Signaling Peptides and Proteins
  • Naphthalenes
  • Pyridines
  • Sulfonamides
  • tcdA protein, Clostridium difficile
  • toxB protein, Clostridium difficile
  • ML 7
  • Y 27632
  • Serotonin
  • W 7
  • ADP Ribose Transferases
  • exoenzyme C3, Clostridium botulinum
  • Protein Serine-Threonine Kinases
  • rho-Associated Kinases
  • Protein Kinase C
  • Calcium-Calmodulin-Dependent Protein Kinases
  • Myosin-Light-Chain Kinase
  • Botulinum Toxins
  • rho GTP-Binding Proteins
  • calphostin C
  • Potassium
  • Ro 31-8220